ICARES Medicus, Inc. (TPEX:6612)

Market Cap	3.52B -33.1%
Revenue (ttm)	1.13B +13.6%
Net Income	42.22M -66.9%
EPS	0.89 -67.1%
Shares Out	47.34M
PE Ratio	83.61
Forward PE	n/a
Dividend	0.30 (0.39%)
Ex-Dividend Date	Aug 22, 2025

Volume	45,158
Open	75.80
Previous Close	76.10
Day's Range	74.30 - 76.00
52-Week Range	66.00 - 110.50
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and l...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2025, ICARES Medicus's revenue was 1.13 billion, an increase of 31.54% compared to the previous year's 859.79 million. Earnings were 51.23 million, a decrease of -50.32%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 9, 2026

Data Sources Report a data error